...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Estimated Glomerular Filtration Rate

"Should RVX-208 improve eGRF, would this synergy be part and parcel of the existing RVX-208 patent, or would it need to be covered by a new patent?"

Great question. Alkaline phosphatase, eGFR, MACE benefit in CKD group and below median LDL-C, heart failure, cognition. I'm very excited to hear more tomorrow about results and patent(s). I'm not sure what all is covered or not in current parents. 

BDAZ

Share
New Message
Please login to post a reply